Association of late gadolinium enhancement with prognosis and sudden cardiac death risk in non-ischemic dilated cardiomyopathy

31 August 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Mr Ibon Rodriguez-Sanchez

Hospital of Galdakao, Galdakao (Spain)

9 More presentations in this session

Presentation thumbnail

Future risk of bradyarrhythmias in patients with hypertrophic cardiomyopathy and implantable cardioverter defibrillator indication

Doctor K. Nakasuka (Suita, JP)

Abstract Slides

Presentation thumbnail

Dilated cardiomyopathy - a group that does not benefit from ICD?

Doctor P. Silverio Antonio (Lisbon, PT)

Abstract Slides

Presentation thumbnail

Implantable cardioverter defibrillators in patients with electrical heart disease and hypertrophic cardiomyopathy - data from the German device Registry

Professor G. Frommeyer (Munster, DE)

Presentation thumbnail

Incidence of appropriate implantable cardioverter defibrillator therapy and sudden cardiac death in cardiac sarcoidosis - a systematic review and meta-analysis

Mr K. Franke (Adelaide, AU)

Abstract Slides

Presentation thumbnail

Assessment of clinical risk factors for all-cause mortality among hypertrophic cardiomyopathy patients with ICDs.

Mr S. Mielczarek (Warsaw, PL)

Abstract Slides

Access the full session

Session thumbnail

Poster Session 1 - Arrhythmia in cardiomyopathy

The Event

ESC Congress 2019

31 August - 4 September 2019

You may be interested in

Congress Session

Risk assessment and prevention of sudden cardiac death in cardiomyopathies

Congress Presentation

Is left ventricular ejection fraction an effective predictor of ventricular arrhythmias in patients with dilated cardiomyopathy?

Congress Presentation

When to consider device therapy in HFrEF - discussion

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources